Status:
COMPLETED
FDG (Fluorodeoxyglucose) Findings After COVID-19 Vaccination
Lead Sponsor:
Kocaeli University
Conditions:
Vaccine Reaction
Oncology
Eligibility:
All Genders
18+ years
Brief Summary
It is important to evaluate the vaccine-related metabolic changes on FDG PET/CT to avoid confusing results. The investigators aimed to assess the frequency and intensity of regional and systemic metab...
Eligibility Criteria
Inclusion
- patients referred for post-vaccination FDG PET/CT imaging
Exclusion
- Disseminated metastatic disease, ipsilateral breast cancer or lymphoma that was likely to involve axilla, and patients who had ipsilateral intense axillary uptake or thyroiditis on their prior imaging, were exclusion criteria
Key Trial Info
Start Date :
July 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 10 2022
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT05270967
Start Date
July 29 2021
End Date
January 10 2022
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kocaeli University School of Medicine Dep. of Nuclear Medicine
Kocaeli, Turkey (Türkiye), tr-41650